Published in Open Addict J on November 11, 2011
Lower glutamic acid decarboxylase 65-kDa isoform messenger RNA and protein levels in the prefrontal cortex in schizoaffective disorder but not schizophrenia. Biol Psychiatry (2014) 0.98
Major depressive disorder: mechanism-based prescribing for personalized medicine. Neuropsychiatr Dis Treat (2015) 0.85
Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia. PLoS One (2015) 0.81
Medication adherence and its determinants among psychiatric patients in an Ethiopian referral hospital. Patient Prefer Adherence (2014) 0.78
Consumers' Experiences in Dual Focus Mutual Aid for Co-occurring Substance Use and Mental Health Disorders. Subst Abuse (2013) 0.77
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Prefer Adherence (2017) 0.75
Prevalence and predictors of sub-optimal medication adherence among patients with severe mental illnesses in a tertiary psychiatric facility in Maiduguri, North-eastern Nigeria. Pan Afr Med J (2015) 0.75
Risk factors for medication non-adherence among psychiatric patients with substance misuse histories. Ment Health Subst Use (2014) 0.75
Mixed-methods analysis of internalized stigma correlates in poorly adherent individuals with bipolar disorder. Compr Psychiatry (2016) 0.75
A systematic review of the associations between dose regimens and medication compliance. Clin Ther (2001) 9.23
Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry (2002) 5.25
Development of a short 'readiness to change' questionnaire for use in brief, opportunistic interventions among excessive drinkers. Br J Addict (1992) 5.02
Measuring processes of change: applications to the cessation of smoking. J Consult Clin Psychol (1988) 4.45
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry (1999) 3.48
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry (2009) 3.36
Compliance with medication regimens for mental and physical disorders. Psychiatr Serv (1998) 3.35
Interventions to improve medication adherence in schizophrenia. Am J Psychiatry (2002) 2.78
Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res (2000) 2.57
Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract (2009) 1.87
Client outcomes II: Longitudinal client data from the Colorado treatment outcome study. Milbank Q (1994) 1.83
Support, mutual aid and recovery from dual diagnosis. Community Ment Health J (2000) 1.61
Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry (2005) 1.50
Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. J Clin Psychiatry (2008) 1.49
Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv (2007) 1.46
A pilot study of barriers to medication adherence in schizophrenia. J Clin Psychiatry (2004) 1.43
Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction (2004) 1.43
Psychosocial factors and medication adherence in HIV-positive youth. AIDS Patient Care STDS (2006) 1.38
Adherence to medication regimens and participation in dual-focus self-help groups. Psychiatr Serv (2002) 1.32
DOUBLE TROUBLE IN RECOVERY: SELF-HELP FOR PEOPLE WITH DUAL DIAGNOSES. Psychiatr Rehabil J (1998) 1.28
A comparative evaluation of substance abuse treatment: V. Substance abuse treatment can enhance the effectiveness of self-help groups. Alcohol Clin Exp Res (1999) 1.27
The role of self-help programs in the rehabilitation of persons with severe mental illness and substance use disorders. Community Ment Health J (1996) 1.23
Medication adherence in schizophrenia: exploring patients', carers' and professionals' views. Schizophr Bull (2006) 1.22
Medication compliance among patients with bipolar disorder and substance use disorder. J Clin Psychiatry (1998) 1.20
Psychiatric patients' attitudes about medication and factors affecting noncompliance. Psychiatr Serv (1997) 1.14
A prospective, multicenter study of patients' refusal of antipsychotic medication. Arch Gen Psychiatry (1990) 1.02
Characteristics of patients with schizophrenia who do not believe they are mentally ill. J Nerv Ment Dis (2001) 1.02
Effects of caregivers' perceived stigma and causal beliefs on patients' adherence to antidepressant treatment. Psychiatr Serv (2005) 0.96
The Drug Avoidance Self-Efficacy Scale. J Subst Abuse (1995) 0.95
Dual-focus mutual aid for co-occurring disorders: a quasi-experimental outcome evaluation study. Am J Drug Alcohol Abuse (2008) 0.93
Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability. J Nerv Ment Dis (2005) 0.93
Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders. J Psychoactive Drugs (1999) 0.91
Consumer Evaluation of Dual Focus Mutual Aid. J Dual Diagn (2008) 0.90
Helping partnerships that facilitate recovery from severe mental illness. J Psychosoc Nurs Ment Health Serv (2008) 0.79
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA (2003) 4.25
Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend (2007) 3.44
Psychiatric impact of gender-related abuse across the life course of male-to-female transgender persons. J Sex Res (2010) 1.97
Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial. Drug Alcohol Depend (2008) 1.79
A further assessment of Blanchard's typology of homosexual versus non-homosexual or autogynephilic gender dysphoria. Arch Sex Behav (2009) 1.41
Lifetime risk factors for HIV/sexually transmitted infections among male-to-female transgender persons. J Acquir Immune Defic Syndr (2009) 1.35
Outcomes of buprenorphine maintenance in office-based practice. J Addict Dis (2007) 1.34
Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients. J Clin Psychiatry (2009) 1.33
Adherence to medication regimens and participation in dual-focus self-help groups. Psychiatr Serv (2002) 1.32
Prevalence and characteristics of chronic pain in patients admitted to an outpatient drug and alcohol treatment program. Pain Med (2008) 1.31
Prescription drugs purchased through the internet: who are the end users? Drug Alcohol Depend (2010) 1.28
Gender abuse, depressive symptoms, and HIV and other sexually transmitted infections among male-to-female transgender persons: a three-year prospective study. Am J Public Health (2012) 1.26
Post-marketing surveillance of methadone and buprenorphine in the United States. Pain Med (2010) 1.25
Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Serv Res (2007) 1.18
Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance. J Psychoactive Drugs (2010) 1.13
Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S. Int J Drug Policy (2007) 1.13
Assessment of the abuse of tapentadol immediate release: the first 24 months. J Opioid Manag (2012) 1.11
Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations. J Addict Dis (2012) 1.08
Hepatitis C knowledge among staff in U.S. drug treatment programs. J Drug Educ (2006) 1.08
Distance traveled and cross-state commuting to opioid treatment programs in the United States. J Environ Public Health (2011) 1.03
Substance use among young adolescents in HIV-affected families: resiliency, peer deviance, and family functioning. Subst Use Misuse (2005) 1.03
The effect of 12-step based fellowship participation on abstinence among dually diagnosed persons: a two-year longitudinal study. J Psychoactive Drugs (2004) 1.03
Predicting treatment retention with a brief "Opinions About Methadone" scale. J Psychoactive Drugs (2006) 1.01
Role of self-help processes in achieving abstinence among dually diagnosed persons. Addict Behav (2003) 0.99
Drug problem recognition, desire for help, and treatment readiness in a soup kitchen population. Subst Use Misuse (2002) 0.97
Gender abuse and major depression among transgender women: a prospective study of vulnerability and resilience. Am J Public Health (2013) 0.96
Psychometric utility of the childhood trauma questionnaire with female street-based sex workers. J Trauma Dissociation (2004) 0.94
Prevalence and correlates of posttraumatic stress disorder and chronic severe pain in psychiatric outpatients. J Rehabil Res Dev (2007) 0.94
Dual-focus mutual aid for co-occurring disorders: a quasi-experimental outcome evaluation study. Am J Drug Alcohol Abuse (2008) 0.93
Buprenorphine-naloxone maintenance following release from jail. Subst Abus (2012) 0.92
Predictive validity of the ASAM Patient Placement Criteria for naturalistically matched vs. mismatched alcoholism patients. Am J Addict (2003) 0.91
Mediators of effectiveness in dual-focus self-help groups. Am J Drug Alcohol Abuse (2003) 0.91
Levels of psychopathy and its correlates: a study of incarcerated youths in three states. Behav Sci Law (2007) 0.90
Consumer Evaluation of Dual Focus Mutual Aid. J Dual Diagn (2008) 0.90
Linking female sex workers with substance abuse treatment. J Subst Abuse Treat (2004) 0.89
Treating cocaine-using methadone patients: predictors of outcomes in a psychosocial clinical trial. Subst Use Misuse (2002) 0.89
Correlates of drug treatment program staff's self efficacy to support their clients' hepatitis C virus (HCV) related needs. Am J Drug Alcohol Abuse (2007) 0.88
Homelessness, substance misuse, and access to public entitlements in a soup kitchen population. Subst Use Misuse (2003) 0.88
Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes. J Subst Abuse Treat (2012) 0.87
Predictors of drinking outcomes among alcoholics. Am J Drug Alcohol Abuse (2003) 0.87
Psychometric properties of the Toronto Alexithymia Scale (TAS-20) for substance users. J Psychosom Res (2005) 0.86
Gender abuse, depressive symptoms, and substance use among transgender women: a 3-year prospective study. Am J Public Health (2014) 0.86
Efficacy of the customized employment supports (CES) model of vocational rehabilitation for unemployed methadone patients: preliminary results. Subst Use Misuse (2004) 0.85
Gender Abuse and Incident HIV/STI Among Transgender Women in New York City: Buffering Effect of Involvement in a Transgender Community. AIDS Behav (2015) 0.85
The combined effects of treatment intensity, self-help groups and patient attributes on drinking outcomes. J Psychoactive Drugs (2005) 0.85
Broadening perspectives on mobile medical outreach to homeless people. J Health Care Poor Underserved (2003) 0.85
Age differences in heroin and prescription opioid abuse among enrolees into opioid treatment programs. Subst Abuse Treat Prev Policy (2011) 0.83
Drug abuse, risks of infectious diseases and service utilization among former Soviet Union immigrants: a view from New York City. J Ethn Subst Abuse (2006) 0.82
Substance user treatment program quality: selected topics. Subst Use Misuse (2002) 0.82
Exploring relations among traumatic, posttraumatic, and physical pain experiences in methadone-maintained patients. J Pain (2010) 0.82
Patients as collaborators: using focus groups and feedback sessions to develop an interactive, web-based self-management intervention for chronic pain. Pain Med (2013) 0.81
Factor structure of the Conners Adult ADHD Rating Scale (CAARS) for substance users. Addict Behav (2005) 0.81
Validity of self-reported misuse of prescription opioid analgesics. Subst Use Misuse (2010) 0.80
Motivationally enhanced group counseling for substance users in a soup kitchen: a randomized clinical trial. Drug Alcohol Depend (2005) 0.80
Undiagnosed Drug Misuse among Admissions to Psychiatric Day Treatment and Prediction of Early Exit. Open Addict J (2010) 0.78
Factors associated with mental health clinicians' referrals to 12-Step groups. J Addict Dis (2012) 0.78
Self-reported side effects in buprenorphine and methadone patients receiving antiretroviral therapy: results from the MANIF 2000 cohort study. Addiction (2010) 0.78
Substance Use and Mental Health Outcomes for Comorbid Patients in Psychiatric Day Treatment. Subst Abuse (2009) 0.78
Improving treatment engagement and outcomes for cocaine-using methadone patients. Am J Drug Alcohol Abuse (2002) 0.78
Consumers' Experiences in Dual Focus Mutual Aid for Co-occurring Substance Use and Mental Health Disorders. Subst Abuse (2013) 0.77
Conducting Rapid Street Assessment of Drug Users in New York City Using Oral Fluid and Brief Interviews: A Feasibility Study. J Addict Dis (2015) 0.75
The limitations of Blanchard's typology: a response to Lawrence (2010). Arch Sex Behav (2010) 0.75
Patient vs provider reports of aberrant medication-taking behavior among opioid-treated patients with chronic pain who report misusing opioid medication. Pain (2016) 0.75
Psychotic ideation and receipt of government entitlements among homeless persons in New York City. Psychiatr Serv (2002) 0.75
The most critical unresolved issue associated with: psychoanalytic theories of addiction: can the talking cure tell us anything about substance use and misuse? Subst Use Misuse (2013) 0.75
Characteristics of Non-Opioid Substance Misusers Among Patients Enrolling in Opioid Treatment Programs: A Latent Class Analysis. J Addict Dis (2015) 0.75